Market Scope

Trusted Partner of Industry and Medical Professionals for Market Data, Independent Perspective, & Objective Analysis

Latest Reports Latest News

Market Scope Methodology

A Multi-Step Approach for Accurate & Timely Data

Proprietary data

  • 20+ years of physician survey data
  • Disease models
  • Cultivated database of physicians, ASCs, and hospitals
  • Insight from our team of in-house industry experts

Public data

  • Attendance and participation at major, worldwide meetings
  • Public health systems and registries
  • Clinical study data
  • Analysis of company-published financial reports

Physician Surveys

For 20+ years, we have surveyed physicians to provide both physicians & industry professionals unbiased insight into the market.

Complete a Survey

On average, our surveys take only 5 to 15 minutes to complete. Survey results help you analyze practice patterns, evaluate treatment choices, and benchmark your practice.

Benchmark Your Performance

Benchmark reports allow you to gauge your performance, track your practice metrics over time, and compare your practice to national averages.

View Market Insights & Analytics

Additional free data tools include instant survey results, weekly polls, PowerPoint charts, and more.

Learn More Register Today

Latest Market Reports

Market Scope's industry reports are meticulously prepared by a dedicated team of in-house consultants/analysts with over 100 years of collective experience.

Latest Industry News & Trends

1/26/2021
COVID-19IndustryNewsletterOphthalmicSurgery
2020 in Review: COVID-19 Derails Ophthalmology’s Hopes for Year Celebrating 20/20 Vision
2020 in Review: COVID-19 Derails Ophthalmology’s Hopes for Year Celebrating 20/20 Vision

Many ophthalmic companies and practices entered 2020 seeing the date as a marketing gift to promote all things related to quality vision. It was to be a banner year. 2020 ended with the number perm...

1/26/2021
CataractIOLNewsletterOphthalmic
Alcon Vivity Launch Expected to Expand PC-IOLs’ Market Share in US
Alcon Vivity Launch Expected to Expand PC-IOLs’ Market Share in US

Alcon on Jan. 7 announced the commercial launch of the AcrySof IQ Vivity non-diffractive extended depth of focus (EDOF) IOL, including a toric version, in the US. We project the Vivity will help dr...

1/26/2021
DealsFundingNewsletterOphthalmic
Ophthalmic Fundraising Activity Soars in the Face of Global Pandemic
Ophthalmic Fundraising Activity Soars in the Face of Global Pandemic

The ophthalmic market continues to expand and attract funding from investors. There were more deals in 2020 than the two previous years, and transactions totaled $8.6 billion. Retina is the largest...

1/26/2021
Dry EyeNewsletterOphthalmicPharma
Kala Launches Eysuvis for Short-Term Treatment of Dry Eye
Kala Launches Eysuvis for Short-Term Treatment of Dry Eye

Kala Pharmaceuticals announced Jan. 7 that it had launched Eysuvis (loteprednol etabonate ophthalmic suspension) 0.25% for the short-term (up to two weeks) treatment of the signs and symptoms of dr...

1/26/2021
AcquisitionsDealsNewsletterOphthalmicRetina
Pixium, Second Sight to Combine Operations, with New Company Trading on Nasdaq
Pixium, Second Sight to Combine Operations, with New Company Trading on Nasdaq

French company Pixium Vision and Second Sight Medical Products, of California, announced Jan. 6 that the two would combine operations. Pixium will contribute to Second Sight all of its assets and l...

1/26/2021
NewsletterOphthalmicRegulation
US Regulatory Roundup: Ophthalmologists Now to See Increase in 2021
US Regulatory Roundup: Ophthalmologists Now to See Increase in 2021

A US spending package signed into law on Dec. 27 erased the impact of Medicare’s negative physician fee adjustments for eye care providers in 2021. Ophthalmologists were prepared to see an average ...

1/26/2021
DeviceNewsletterOphthalmicRegulation
US FDA PMA Approvals and 510(k) Clearances for December 2020
US FDA PMA Approvals and 510(k) Clearances for December 2020

The US FDA’s ophthalmic devices division granted four clearances through the 510(k) pathway in December 2020, according to the agency’s database. One involved adding an indication for use to an alr...

1/26/2021
COVID-19IndustryNewsletterOphthalmicSurgery
2020 in Review: Corporate, Surgeon Picks for Top Stories
2020 in Review: Corporate, Surgeon Picks for Top Stories

Market Scope polled companies and practices to rank our list of top 10 ophthalmic stories for 2020. Not surprisingly, both groups chose the COVID-19 pandemic as the No. 1 story. Corporate participa...

Join Market Scope Today

Register A Corporate Account

A corporate accounts gives you access to licensed reports and subscriptions, the latest news, and a personalized dashboard.

Select one or more
Select one or more

Register A Clinical Account

A clinical account gives you access to survey participation and results, weekly polls, benchmark reports, a searchable news archive, and more on a personalized dashboard.

United States
US Surveys
May select more than one

Market Scope

13421 Manchester Road, Suite 201 | St. Louis, MO 63131 | Phone: 314-835-0600 | Email: info@market-scope.com

©2021 Market Scope, LLC. All Rights reserved.